Course / Who Needs ICSI & Who Doesn’t?
ICSI is primarily indicated when natural sperm–egg interaction is likely to fail.
From a clinical standpoint, ICSI should be considered necessary under the following conditions:
Severe male-factor infertility (oligozoospermia, asthenozoospermia, teratozoospermia)
Use of surgically retrieved sperm (PESA, TESA, or micro-TESE)
History of fertilization failure in prior IVF cycles
Use of frozen/thawed sperm or eggs
Presence of anti-sperm antibodies or sperm functional defects
The goal is to achieve consistent fertilization while minimizing unnecessary manipulation of gametes.
Numerous clinical trials and meta-analyses have evaluated ICSI use in both male- and non-male-factor infertility.
The results are clear:
For severe male-factor infertility, ICSI substantially improves fertilization and live birth rates.
For non-male-factor infertility, ICSI does not consistently increase pregnancy or live birth outcomes.
Data from Cochrane reviews and ASRM/ESHRE guidelines emphasize that routine ICSI in non-male-factor cases offers no statistical advantage over conventional IVF, but adds cost and lab workload.
Therefore, ICSI remains a precision tool, not a universal default.
In practice, many IVF laboratories automatically perform ICSI whenever a semen abnormality is noted.
However, experts recognize that:
Mild male-factor infertility may still achieve satisfactory fertilization with conventional insemination.
Threshold values (e.g., total motile sperm count <1 million or <5% normal morphology) truly justify ICSI.
When sperm function tests (e.g., DNA fragmentation index, HBA binding, acrosome reaction tests) are borderline normal, clinicians can consider split insemination protocols—half of the eggs by IVF, half by ICSI—to assess sperm performance.
Key takeaway: Use ICSI where there’s clear evidence of impaired sperm function—not as reflex.
In non-male-factor infertility (normal semen parameters), ICSI does not improve clinical pregnancy or live birth rates.
Routine use in such cases can:
Introduce unnecessary handling risks for oocytes
Increase cost per cycle
Add lab workload without outcome benefit
Clinical consensus recommends standard IVF insemination for normal sperm profiles unless specific risk factors (previous low fertilization, cryopreservation issues) exist.
Unexplained infertility involves couples with normal sperm, ovulation, and tubal patency but failed conception.
Studies indicate no additional benefit of ICSI in these cases.
The underlying issue may relate to embryo genetics or implantation, not sperm–egg interaction.
ICSI may be considered only after previous IVF cycles result in <25% fertilization or total fertilization failure (TFF).
In cycles with ≤3 mature oocytes, many clinics use ICSI to maximize fertilization chances since each egg is precious.
Although evidence is mixed, ICSI ensures that each available oocyte gets a direct fertilization attempt.
This is especially relevant when oocyte quality or zona pellucida thickness is suboptimal.
However, clinicians must weigh the additional cost and lab time against expected benefit.
Older oocytes often have zona hardening or cytoplasmic changes affecting sperm penetration.
ICSI may overcome these mechanical barriers, improving fertilization consistency.
While ICSI doesn’t correct age-related aneuploidy, it reduces failed fertilization events in older patients.
Expert labs frequently apply selective ICSI in patients ≥38 years with prior suboptimal fertilization.
Advanced paternal age (>45 years) can correlate with increased sperm DNA fragmentation and subtle motility dysfunction.
While conventional insemination may still succeed, ICSI ensures fertilization consistency.
Use of ICSI may also facilitate sperm selection techniques (e.g., PICSI, IMSI) to minimize DNA-damaged sperm injection.
Evidence supports its use in specific cases of paternal aging, particularly when combined with mild male-factor parameters.
Prior IVF cycles with no fertilization or ≤25% fertilization strongly indicate gamete interaction defects.
In subsequent cycles, ICSI is the preferred and justified approach.
ICSI bypasses sperm–zona interaction barriers, yielding significantly higher fertilization recovery rates.
Clinics should always review prior cycle lab data before designating a “TFF” case for ICSI.
In tubal infertility, sperm and oocyte quality are often normal.
ICSI is not automatically required unless prior fertilization issues exist.
In such cases, standard IVF insemination should remain first-line.
ICSI can be reserved as a backup if fertilization failure occurs.
Vitrification can induce subtle zona hardening or membrane changes that reduce sperm penetration.
For this reason, ICSI is standard practice when using thawed oocytes, regardless of sperm parameters.
It enhances fertilization rates and ensures consistency across donor egg programs.
Thawed sperm often show reduced motility and acrosomal integrity.
ICSI compensates for post-thaw sperm damage, ensuring fertilization success.
It is routinely recommended when using cryopreserved or surgically retrieved sperm.
ICSI utilization in the U.S. exceeds 70% of IVF cycles — far above the true clinical need.
Reasons include:
Fear of fertilization failure (lab or clinician risk aversion)
Economic incentives (additional lab fees)
Patient demand or misunderstanding (“ICSI guarantees success”)
Routine lab policy instead of individualized indication
Misinterpretation of marginal sperm data
As fertility professionals, it is our responsibility to apply ICSI selectively—balancing patient success with evidence-based practice.
ICSI utilization in the U.S. exceeds 70% of IVF cycles — far above the true clinical need.
Reasons include:
Fear of fertilization failure (lab or clinician risk aversion)
Economic incentives (additional lab fees)
Patient demand or misunderstanding (“ICSI guarantees success”)
Routine lab policy instead of individualized indication
Misinterpretation of marginal sperm data
As fertility professionals, it is our responsibility to apply ICSI selectively—balancing patient success with evidence-based practice.
| Perform diagnostic semen function tests early | Use HBA binding, SCSA, or DNA fragmentation assays before deciding on ICSI |
| Consider split insemination protocols | Divide retrieved oocytes between IVF and ICSI to assess sperm capability objectively |
| Evaluate oocyte maturity carefully | Only MII oocytes should undergo ICSI—GV and MI stages risk degeneration |
| Review previous fertilization metrics | Use lab data trends (fertilization %, degeneration rate, pronuclear formation) for decision-making |
| Avoid reflex ICSI for convenience | Base each cycle on individualized clinical and lab assessment |
| Communicate with embryology teams | Regular case reviews prevent unnecessary ICSI use and improve outcomes |
| Educate patients transparently | Explain when ICSI helps and when it adds no measurable benefit |
| Track ICSI outcome metrics per embryologist | Monitor fertilization and degeneration rates for continuous improvement |
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Surrogacy4All is a unique international surrogacy service targeted at providing state of the art IVF and surrogacy services to Intended Parents irrespective of age, sex or color, at the lowest possible cost in the world.
Secret Guide to Minimizing Surrogacy Costs
All Rights Reserved to Surrogacy4all